OUR BLOG
Latest Updates & News
At vero eos et accusamus iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos at dolores molestias excepturi sint occaecati cupiditate.
World Vaccine Congress Europe 2026
When 19-21 October 2026Location Amsterdam, NetherlandsJoin P95 Julius Clinical at World Vaccine Congress 2026 in...
Poster Presentation: Understanding severe respiratory infections in medically vulnerable adults across Europe: New insights from the id.DRIVE Network
Presented at the European Respiratory Society (ERS) International Congress 2026, this poster explores the demographic...
ISPE 2026 Takeaways: Real-World Evidence, Methodological Precision, AI and More Representative Research
ISPE 2026 Takeaways: Real-World Evidence, Methodological Precision, AI & More Representative Research
Research at the Speed of Outbreak
No licensed vaccine or therapeutic exists for the Bundibugyo Ebola strain. Drawing on five landmark outbreak trials, this white paper outlines the clinical research and vaccine development strategies needed to close the gap, and what sponsors, CROs, and regulators should do now.
New Paths to Proof: Real-World Evidence and Adaptive Design in Complex Disease Research
Adaptive designs and real-world evidence are changing how efficacy is proven with traditional phase III trials fall short; a P95 Julius Clinical perspective.
Pallas Health Research and Consultancy: A Legacy Continued Within P95
Pallas Health Research and Consultancy was a Dutch research and advisory organization specializing in epidemiology,...
Vaccine Clinical Development Plan Webinar: Drafting a CDP
The Vaccine Clinical Development Plan Webinar: Drafting a CDP is part of The Council for the Promotion of...
Assign DMB: A Legacy Continued Within P95
Discover the history of Assign DMB, an Austrian CRO founded in 2005. Learn how its expertise in data management and biostatistics continues today as part of P95
4Clinics: A Legacy Continued Within P95
Explore the history of 4Clinics, a CRO founded in 1997 with expertise in vaccines and immunotherapeutics. Discover how its capabilities continue today within P95.
OnQ Research: A Legacy Continued Within P95
Discover the history of OnQ Research, a pioneering African CRO founded in 1999. Learn how OnQ’s clinical trial expertise continues today as part of P95.
The Importance of Medical Writing for Infectious Disease and Vaccine Programs
See how P95 can support with medical writing for vaccine programs or infectious disease research from regulatory documents to protocols
P95 Partners in South Africa’s Historic Cholera Vaccine Clinical Trial (OcV-S)
P95 is proud to serve as the selected CRO for the cholera vaccine clinical trial of OCV-S, South Africa’s first fully homegrown vaccine
P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence
P95 and Julius Clinical merge forming a 500+ person global CRO spanning 25+ countries with operations in North America, Europe, Africa, Latin America, and Asia-Pacific
qualitative burden of disease study: patients with ied aged ≥ 60 years in the United States
Background Invasive Escherichia coli disease (IED) comprises a diverse range of severe infections caused by E. coli,...
Latin America Rising Role In Global Clinical Research: Opportunities Ahead
Discover how Latin America Rising Role In Global Clinical Research with Rodrigo de Antonio joins and Tom Verstraeten
Conducting Infectious Disease Trials in Low-Income Countries
Discover how conducting infectious disease trials in low-income countries advances global health and improves treatment access.
Systematic Literature Review: Burden of hMPV in Older and High-Risk Adults in Developed Countries
Introduction Human metapneumovirus (hMPV) causes respiratory infections in individuals of all age groups. While the...
Running Vaccine Trials in Africa: What You Need to Know
Learn about about what it truly takes to run vaccine trials in Africa today in this podcast episode
How to Design Phase I Vaccine Studies in Europe Webinar
The How to Design Phase I Vaccine Studies in Europe Webinar is a focused session for sponsors and biotech leaders...
Origins, Growth & Evidence Strategy in Infectious Disease Research
Contagious Thinking Podcast Episode One: Origins, Growth & Evidence Strategy in Infectious Disease Research with P95 CEO Thomas